ArticleCommunications biology2025
Multilayer Integration of Networks Toolbox (MINT).
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We present MINT (Multilayer Integration of Networks Toolbox), a Python package for multimodal data integration and community detection. MINT includes data standardization, Similarity Network Fusion, Generalized Louvain clustering, visualization, cross-validation, and modality selection optimization, capturing complex relationships among disease markers. We applied MINT to two multimodal datasets spanning the Alzheimer's disease (AD) spectrum: a primary cohort of 206 participants and a validation cohort of 143 participants, including structural magnetic resonance imaging (MRI), amyloid positron emission tomography (PET), cerebrospinal fluid (CSF), cognition, and genetics. We hypothesized that modeling intra- and inter-modality associations would improve AD prediction and identify preclinical cases. Across both datasets, MINT identified PET and CSF as optimal modalities and detected two communities: one AD-dominant and one cognitively normal-dominant (CN). Sensitivity and specificity for CN and AD were 84.38% (95% CI: 73.14-92.24) and 92.65% (95% CI: 83.67-97.57). The AD-dominant community exhibited poorer cognition and higher genetic risk and AD pathology (p < 0.001). CN individuals in this group showed elevated amyloid (p=0.009), tau (p=0.004), and ptau (p < 0.001) compared to AD individuals in the CN-dominant group. MINT can identify biologically relevant subgroups, predict disease progression, and serves as a powerful tool for uncovering complex relationships across heterogeneous and multifactorial disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.